|
ZNF433 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.78460000110903E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.03279999999584E-05 |
| Normal-vs-Stage2 |
7.957900E-04 |
| Normal-vs-Stage3 |
2.43599584948129E-11 |
| Normal-vs-Stage4 |
8.30910000026996E-07 |
| Stage1-vs-Stage2 |
8.342400E-01 |
| Stage1-vs-Stage3 |
1.71988999999595E-05 |
| Stage1-vs-Stage4 |
2.767700E-02 |
| Stage2-vs-Stage3 |
5.775600E-03 |
| Stage2-vs-Stage4 |
6.323700E-02 |
| Stage3-vs-Stage4 |
8.448800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.41550005050561E-09 |
| Normal-vs-AfricanAmerican |
5.208100E-04 |
| Normal-vs-Asian |
2.319200E-03 |
| Caucasian-vs-AfricanAmerican |
1.065190E-01 |
| Caucasian-vs-Asian |
5.855200E-01 |
| AfricanAmerican-vs-Asian |
3.557400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.13490003242845E-09 |
| Normal-vs-Female |
2.3445999999927E-05 |
| Male-vs-Female |
2.405400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.52730000000068E-05 |
| Normal-vs-Extreme_Weight |
2.2972999946802E-08 |
| Normal-vs-Obese |
1.18480000033117E-07 |
| Normal-vs-Extreme_Obese |
4.277400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.914400E-01 |
| Normal_Weight-vs-Obese |
4.544800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.206800E-01 |
| Extreme_Weight-vs-Obese |
9.458600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.851200E-01 |
| Obese-vs-Extreme_Obese |
2.949200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.50449999999958E-05 |
| Normal-vs-Age(41-60Yrs) |
1.85040000000303E-06 |
| Normal-vs-Age(61-80Yrs) |
6.80870000380196E-08 |
| Normal-vs-Age(81-100Yrs) |
2.44289999995484E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.509600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.070000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.792400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.081600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.349900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.407370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.51410000004404E-06 |
| Normal-VS-Type2 PRCC |
3.25406368517633E-13 |
| Normal-VS-KIRP CIMP |
6.39940000990435E-09 |
| Normal-VS-Unclassified PRCC |
8.98769999535531E-08 |
| Type1 PRCC-VS-Type2 PRCC |
7.50210000011187E-07 |
| Type1 PRCC-VS-KIRP CIMP |
3.29229999995739E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
5.440500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.924100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.981900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.056420E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.17429999560537E-08 |
| Normal-vs-N1 |
1.66290314851381E-11 |
| Normal-vs-N2 |
2.45819999999952E-05 |
| N0-vs-N1 |
9.101000E-03 |
| N0-vs-N2 |
3.626400E-02 |
| N1-vs-N2 |
1.972240E-01 |
|
|
